Australia's Universal Biosensors jumps on approval for device sale in Europe

Universal Biosensors

04/10/2023 04:12

** Shares of Universal Biosensors  UBI.AX  rise as much as
9.3% to A$0.295, set for best day since Sept. 20, if gains hold
    ** Biosensor maker says it has received approval required
for the sale of its coagulation analyzer 'Xprecia Prime 4U'
directly to patients for self-testing in Europe
    ** The approval is in the form of the 'EU Technical
Documentation Assessment Certificate', issued by Notified Body
-TÜV SÜD Product Service GmbH
    ** Stock at highest level since Sept. 21
    ** 219,686 shares change hands, compared with the 30-day
average volume of 64,644
    ** Stock has risen 20% YTD, as of last close

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))